Emerging Infectious Diseases (Dec 2024)

Mpox Vaccine Acceptance, Democratic Republic of the Congo

  • Skylar Petrichko,
  • Jason Kindrachuk,
  • Dalau Nkamba,
  • Megan Halbrook,
  • Sydney Merritt,
  • Handdy Kalengi,
  • Leonard Kamba,
  • Michael Beya,
  • Nicole A. Hoff,
  • Christophe Luhata,
  • Didine K. Kaba,
  • Anne W. Rimoin

DOI
https://doi.org/10.3201/eid3012.241226
Journal volume & issue
Vol. 30, no. 12
pp. 2614 – 2619

Abstract

Read online

We report general acceptance (61.0%) of an mpox vaccine in the Democratic Republic of the Congo among 5,226 survey respondents. Healthcare workers and respondents in historic mpox-endemic regions had higher acceptance rates. These data highlight the need for increased community engagement and sensitization before widespread deployment of mpox vaccines.

Keywords